Federated Hermes
TEVA icon

Federated Hermes’s Teva Pharmaceuticals TEVA Stock Holding History

Federated Hermes’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-50,000
Closed -$2.96M – 2041
2015
Q2 		$2.96M Buy
+50,000
New +$3.08M 0.01% 778

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $299B AUM 27.55% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

Federated Hermes's TEVA Position: Q2 2021 in Review

Federated Hermes sold out of Teva Pharmaceuticals (TEVA) in Q2 2021, closing a stake of 7,598 shares — an estimated $88K sold.

Federated Hermes first reported a position in TEVA in Q2 2013 and held it in 21 quarters. The position peaked at $120M in Q2 2015. 440 funds tracked by Wall St. Rank hold TEVA as of Q2 2021.

  • Federated Hermes reported no remaining Teva Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
  • Federated Hermes sold 7,598 Teva Pharmaceuticals shares in Q2 2021, an estimated $88K.
  • Federated Hermes first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 21 quarters.
  • Federated Hermes's Teva Pharmaceuticals position peaked at $120M in Q2 2015.
  • 440 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2021.

Based on Federated Hermes's 13F filing for Q2 2021, filed 16 Aug 2021.